| Financial Year |
March 31 2023 |
| Monetary Funds |
1,214,951,262.08 |
| Held-for-trading Financial Assets |
71,473,336.64 |
| Notes Receivable |
78,890,747.64 |
| Accounts Receivable |
890,431,084.86 |
| Advances to Suppliers |
79,317,455.12 |
| Other Receivables |
16,376,766.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
867,706,681.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
84,667,002.30 |
| Total Current Assets |
3,387,221,446.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
25,241,446.10 |
| Fixed Assetes |
1,840,201,812.47 |
| Under-construction Projects |
1,008,912,198.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
376,639,820.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,975,506.59 |
| Deferred Income Tax Assets |
72,968,830.35 |
| Other Non-Current Assets |
228,168,324.70 |
| Sub-Total of Non-Current Assets |
3,571,814,128.39 |
| Total Assets |
6,959,035,575.15 |
| Short-Term Loans |
2,200,448,945.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
289,018,273.92 |
| Accounts Payable |
602,801,950.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,996,374.69 |
| Taxes Payable |
59,022,874.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,812,095.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
187,510,620.40 |
| Other Current Liabilities |
25,597,251.14 |
| Sub-Total of Current Liabilities |
3,414,201,650.08 |
| Long-term Loans |
581,035,836.79 |
| Bonds Payable |
533,681,647.04 |
| Long-Term Accounts Payable |
19,866,251.64 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,367,388,750.65 |
| Total Liabilities |
4,781,590,400.73 |
| Paid-In Capital(Or Share Stock) |
400,552,720.00 |
| Capital Surplus |
468,992,273.23 |
| Surplus Reserve |
43,570,928.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,108,198,987.28 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,177,445,174.42 |
| Owner's Equity（Stockholder's Equity） |
2,177,445,174.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,959,035,575.15 |
